共 23 条
- [11] Raji L., Azar S., Keasne W.F., Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats, Kidney International, 26, pp. 137-143, (1984)
- [12] Smith H., Principles of renal physiology, pp. 196-215, (1965)
- [13] Diamond J.R., Karnovsky M.J., Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside, Am J Pathol, 122, pp. 481-487, (1986)
- [14] Grond J., Weening J.J., Elema J.D., Glomerular sclerosis in nephrotic rats, Lab Invest, 51, pp. 277-285, (1984)
- [15] Kasiske B.L., O'Donnell M.P., Garvis W.J., Keane W.F., Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure, Circ Res, 62, pp. 367-374, (1988)
- [16] Marinides G.N., Groggel G.C., Cohen A.H., Cook T., Baranowski R.L., Westenfelder C., Border W.A., Failure of angiotesin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy, Am J Pathol, 129, pp. 394-401, (1987)
- [17] Marinides G.N., Groggel G.C., Cohen A.H., Border W.A., Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy, Kidney International, 37, pp. 749-757, (1990)
- [18] Trachtman H., Zavilowitz B., Bennett B., Goldsmith D.I., The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats, Pediatr Res, 19, pp. 823-834, (1985)
- [19] Trachtman H., Del Pizzo R., Valderrama E., Gauthier B., The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy, Pediatr Nephrol, 4, pp. 501-504, (1990)
- [20] Andreoli S.P., Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury, Am J Physiol, 264, pp. F120-F127, (1993)